Partner Content Partner Content Registration Opens for SMi’s 20th Annual Pain Therapeutics C... Registration Opens SMi’s Pain Therapeutics
Partner Content Partner Content 2 weeks until SMi’s 19th Annual Pain Therapeutics Conference... Only 2 weeks to SMi's 19th Annual Pain Therapeutics
Partner Content Partner Content Pain Therapeutics: Interviews AstraZeneca, Ensysce Bioscienc... Pain Therapeutics Exclusive Speaker Interviews Released
Partner Content Partner Content Interview released with Reckitt Benckiser, speaker at Pain T... Interview with Reckitt Benckiser - Pain Therapeutivcs
Partner Content Partner Content Chairs Centrexion Therapeutics & Metys Pharmaceuticals i... Co-Chairs invite to Pain Therapeutics Conference 2019
Events Partner Content SMi’s 19th Annual Pain Therapeutics Conference SMi's 19th Annual Pain Therapeutics Conference
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
